Dominika Tomaniak

Dominika Tomaniak is a Researcher in the Department of Cardiology at Erasmus University Rotterdam's Erasmus School of Medicine, specializing in biomarker validation for chronic heart failure risk prediction. Her work integrates immunology, hematology, and clinical cardiology through longitudinal patient cohort analysis.

Her research focuses on:

• Inflammatory pathways in heart failure progression
• Macrophage/neutrophil-derived biomarkers (CD163, Tartrate-Resistant Acid Phosphatase)
• Dynamic risk modeling using multi-marker panels
• Echocardiographic-biomarker correlations

Analysis of her publications reveals consistent emphasis on temporal biomarker patterns, particularly macrophage-related proteins and established cardiac markers (N-terminal pro BNP, troponin T). Her Bio-SHiFT study investigated 92 biomarkers for personalized risk stratification, demonstrating cross-disciplinary integration of immunology and cardiology to refine heart failure management protocols.

Dr. Tomaniak maintains extensive collaborations across Erasmus MC departments and international institutions, evidenced by multi-center studies involving cardiology, immunology, and epidemiology specialists. Her research utilizes large clinical cohorts with advanced statistical modeling for biomarker trajectory analysis.